Monte Rosa Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Monte Rosa Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Monte Rosa Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $315M, a 25% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$315M	+$63M	+25%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$344M	+$65.5M	+23.5%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$267M	-$42.3M	-13.7%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$304M	-$38.6M	-11.3%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$252M	-$106M	-29.5%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$279M	-$86.4M	-23.7%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$309M	-$37M	-10.7%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$342M	-$23.9M	-6.54%	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$358M	-$26.4M	-6.89%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$365M	-$3.89M	-1.05%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$346M			Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$366M	+$317M	+642%	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$384M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$369M			Jun 30, 2021	10-Q	2021-08-12
Q4 2020	$49.4M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.